Pillstats
Rx only · Tablet · Oral

Sulfadiazine

Sulfadiazine

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)10171
US makers2 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$4.35$8.70$13.05$17.40Mar 2026May 2026Jul 2026
$15.105
Latest avg · Jul 22, 2026
+1%
Since Mar 18, 2026
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

541081612152025 Q12025 Q22025 Q32025 Q42026 Q1
104
Rx · 2026 Q1
12K
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Epic Pharma, LLCunknown1SUPPLYING
Chartwell RX, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.